Home
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell

Clinical trial condition

Leukemia, Lymphocytic, Chronic, B-Cell

Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.

1,434 public trials 165 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Lymphocytic, Chronic, B-Cell trial results

Completed

A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies

NCT00807677

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Advanced Polycythemia, +47 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

NCT00002502

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +69 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

NCT00004132

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +60 more
Locations: Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

View Trial Details

Completed

Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia

NCT00005579

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +24 more
Locations: Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States

Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States

Vermont Cancer Center Burlington, Vermont, United States

View Trial Details

Completed

Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00052416

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +26 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Fletcher Allen Health Care - University Health Center Campus Burlington, Vermont, United States

View Trial Details

Completed

Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer

NCT00004061

Conditions: Blast Crisis, Bone Marrow Diseases, Burkitt Lymphoma, +42 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer

NCT00003395

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +70 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers

NCT00003658

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +24 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer

NCT00006019

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Bronchial Neoplasms, +54 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders

NCT00052572

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

Vermont Cancer Center at University of Vermont Burlington, Vermont, United States

View Trial Details

Leukemia, Lymphocytic, Chronic, B-Cell

Leukemia, Lymphocytic, Chronic, B-Cell trial results

Related conditions